Assetmark Inc. Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Assetmark Inc. boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 46.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,107 shares of the company’s stock after purchasing an additional 2,868 shares during the period. Assetmark Inc.’s holdings in GE HealthCare Technologies were worth $675,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of GEHC. N.E.W. Advisory Services LLC bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth $25,000. Bogart Wealth LLC lifted its stake in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares during the period. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies during the 2nd quarter worth about $34,000. Game Plan Financial Advisors LLC increased its position in GE HealthCare Technologies by 295.3% during the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares during the period. Finally, Zions Bancorporation National Association UT bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $42,000. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of analyst reports. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. BTIG Research set a $87.00 price target on GE HealthCare Technologies in a research note on Wednesday, October 29th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Finally, Citigroup lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Stock Down 1.9%

GEHC opened at $74.17 on Friday. The company has a market cap of $33.79 billion, a PE ratio of 15.32, a price-to-earnings-growth ratio of 2.84 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a 50-day moving average price of $75.13 and a 200 day moving average price of $73.33. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter last year, the business posted $1.14 earnings per share. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.